Cash in the door
Mkango Resources Limited says the money hunt is over: it has closed a £12.5 million fundraise, issuing 37,878,788 new common shares at £0.33 each. In plain English, the company sold fresh stock to raise cash, and now it’s got a bigger war chest — with the usual side effect of dilution hanging around like an uninvited guest.
Where the money’s going
Management says the proceeds are meant to fuel growth opportunities, including:
- a possible acquisition in Germany
- capital spending at its UK and German operations
- working capital, aka the corporate oxygen tank
That’s the kind of wording that tells you the company wants to stay nimble, not just sit on the cash and admire it.
A little insider flavor
One wrinkle: the interim CFO participated in the retail offer for £150,000. The company says that counts as a related party transaction, but it was exempt from the usual valuation and minority-shareholder approval hoops. Not scandalous, but definitely the kind of detail investors like to notice before it quietly becomes a bigger story.
The market math
The new shares have been admitted to trading on AIM and were conditionally accepted for listing on the TSX Venture Exchange, subject to the usual boxes being checked. So if you own the stock, the headline is simple: Mkango got funded, but existing holders now have more shares sitting at the table.
Big picture: this is one of those classic financing moves where the company buys itself time and optionality — and you, as an investor, get to weigh growth potential against dilution.